In another more recent study, in 5‐azadC‐treated FXS‐Neuronal Progenitor Cells, the authors showed an FMR1 mRNA level equivalent to 40% of that in normal cells following 6 days of treatment. This evidence concerns the gene FMR1 and fragile X syndrome.